[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100611729":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":27,"centralContacts":32,"locations":41,"responsibleParty":63,"collaborators":18,"id":67,"slug":68,"hasResults":69,"nctId":70,"briefTitle":71,"officialTitle":72,"acronym":18,"eligibilityCriteria":73,"healthyVolunteers":69,"sex":74,"minAge":75,"maxAge":76,"enrollmentInfo":77,"targetDuration":18,"studyType":80,"phases":81,"briefSummary":83,"conditions":84,"keywords":86,"overallStatus":44,"whyStopped":18,"lastUpdateSubmitDate":89,"lastUpdatePostDateStruct":90,"startDateStruct":93,"completionDateStruct":95,"leadSponsor":97,"locationsCount":98},{"fullName":5,"class":6},"Sohag University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Arm A","ACTIVE_COMPARATOR","will receive SC cytarabine + venetoclax till bone marrow transplantation or for 12 cycles for patient will not undergo BMT , SC Cytarabine (20 mg) administrated on days 1-7 , Venetoclax (100 mg ) administrated on days 1-7 , Voriconazole 200 mg 1x2 administrated on days 1-7 + best supportive care BSC",[13],"Drug: SC cytarabine +Venetoclax",{"label":15,"type":16,"description":17,"interventionNames":18},"Arm B","NO_INTERVENTION","Patients Will receive Best supportive care( BSC )only",null,[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"DRUG","SC cytarabine +Venetoclax","SC Cytarabine (20 mg) administrated on days 1-7 ,,Venetoclax (100 mg ) administrated on days 1-7,,Voriconazole 200 mg 1x2 administrated on days , Best supportive care as needed . Up to 12 cycles or until patients undergo bone marrow transplantation",[9],[26],"Venclexta",[28],{"name":29,"affiliation":30,"role":31},"Elsayed M Ali, Professor","Faculty of medicine sohag university","STUDY_DIRECTOR",[33,39],{"name":34,"role":35,"phone":36,"phoneExt":37,"email":38},"Eman I Abdelshakour, Asst lect","CONTACT","+201063901450","+201122103385","Eman011065@med.sohag.edu.eg",{"name":40,"role":35,"phone":18,"phoneExt":18,"email":18},"Walaa G Mohamed, Lecturer",[42,56],{"facility":43,"status":44,"city":45,"state":18,"zip":18,"country":46,"countryCode":47,"cosmosGeoPoint":48,"geoPoint":53,"contacts":54},"Sohag university hospital","RECRUITING","Sohag","Egypt","EG",{"type":49,"coordinates":50},"Point",[51,52],31.69478,26.55695,{"lat":52,"lon":51},[55],{"name":34,"role":35,"phone":36,"phoneExt":37,"email":38},{"facility":57,"status":44,"city":45,"state":18,"zip":18,"country":46,"countryCode":47,"cosmosGeoPoint":58,"geoPoint":60,"contacts":61},"Sohag university",{"type":49,"coordinates":59},[51,52],{"lat":52,"lon":51},[62],{"name":34,"role":35,"phone":36,"phoneExt":37,"email":38},{"type":64,"investigatorFullName":65,"investigatorTitle":66,"investigatorAffiliation":5,"oldNameTitle":18,"oldOrganization":18},"PRINCIPAL_INVESTIGATOR","Eman Ibrahim Abdelshakour","Assistant lecturer","100611729","maintenance-venetoclax-in-aml-fit-patients-100611729",false,"NCT07244367","Maintenance Venetoclax in AML Fit Patients","Maintenance Venetoclax Based Therapy Post Complete Remission in AML Fit Patients","Inclusion Criteria:\n\n* Age : 18 - 60 years . Patients who are not eligible for immediate bone marrow transplantation. Newly diagnosed AML patients who attained CR after 1st line. Refractory \u002F recurrant AML patients who attained CR after 2nd line .\n\nExclusion Criteria:\n\n* Patients not on CR . Age : younger than 18 or older than 60 . Patients not eligible for bone marrow transplation","ALL","18 Years","60 Years",{"count":78,"type":79},80,"ESTIMATED","INTERVENTIONAL",[82],"NA","this study will explore the efficacy of maintenance SC cytarabine + venetoclax therapy as regard disease free survival (DFS) in AML fit patients who achieved CR after highly aggressive chemotherapy as bridge for BMT or if BMT will be delayed or canceled due to any other reason.",[85],"Acute Myeloid Leukaemia (AML)",[87,88],"AML","Venetoclax","2025-11-17",{"date":91,"type":92},"2025-11-24","ACTUAL",{"date":94,"type":92},"2025-09-01",{"date":96,"type":79},"2027-09-01",{"name":5,"class":6},2]